NUCLEIC ACID PARTICIPATING IN THE FORMATION OF PRESENILIN−2−GENE EXON 5−DEFECTIVE SPLICING VARIANT

摘要

Means of treating and/or preventing diseases caused by a splicing variant, neurodegenerative diseases typified by Alzheimer’s disease and so on. A nucleic acid seemingly participating in the formation of a presenilin−2 exon 5−deficient splicing variant; an inhibitor inhibiting the binding between a protein and a nucleic acid causing the splicing variant; and a method of screening the inhibitor.